These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
639 related articles for article (PubMed ID: 35043090)
1. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients. Subbaram K; Ali PSS; Ali S Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090 [TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. Sen S; Chakraborty R; Kalita P; Pathak MP World J Clin Cases; 2021 Oct; 9(28):8327-8339. PubMed ID: 34754842 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection and smoking: What is the association? A brief review. Gupta I; Sohail MU; Elzawawi KE; Amarah AH; Vranic S; Al-Asmakh M; Al Moustafa AE Comput Struct Biotechnol J; 2021; 19():1654-1660. PubMed ID: 33777332 [TBL] [Abstract][Full Text] [Related]
4. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616 [TBL] [Abstract][Full Text] [Related]
5. COVID-19: a conundrum to decipher. Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923 [TBL] [Abstract][Full Text] [Related]
6. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management. Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639 [TBL] [Abstract][Full Text] [Related]
8. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
9. Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges. Yusuf AP; Zhang JY; Li JQ; Muhammad A; Abubakar MB Phytomed Plus; 2022 Aug; 2(3):100280. PubMed ID: 35463625 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Malekmohammad K; Rafieian-Kopaei M Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607 [TBL] [Abstract][Full Text] [Related]
12. Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus. Liao YH; Zheng JQ; Zheng CM; Lu KC; Chao YC J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33297431 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus. Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Guerreiro SG; Cruz-Martins N; Batiha GE Front Cardiovasc Med; 2021; 8():644095. PubMed ID: 34124187 [TBL] [Abstract][Full Text] [Related]
14. Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation. Nabi AHMN; Ebihara A; Shekhar HU World J Virol; 2023 Jun; 12(3):151-171. PubMed ID: 37396707 [TBL] [Abstract][Full Text] [Related]
15. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature. Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925 [TBL] [Abstract][Full Text] [Related]
16. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis. Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221 [TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection. Vargas-Rodriguez JR; Garza-Veloz I; Flores-Morales V; Badillo-Almaraz JI; Rocha-Pizaña MR; Valdés-Aguayo JJ; Martinez-Fierro ML Front Med (Lausanne); 2021; 8():758414. PubMed ID: 35096863 [TBL] [Abstract][Full Text] [Related]
18. Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection. Norouzi M; Norouzi S; Ruggiero A; Khan MS; Myers S; Kavanagh K; Vemuri R Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34205044 [TBL] [Abstract][Full Text] [Related]
19. New onset diabetes, type 1 diabetes and COVID-19. Boddu SK; Aurangabadkar G; Kuchay MS Diabetes Metab Syndr; 2020; 14(6):2211-2217. PubMed ID: 33395782 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics. Singh SP; Bhatnagar A; Singh SK; Patra SK; Kanwar N; Kanwal A; Amar S; Manna R Mini Rev Med Chem; 2022; 22(16):2102-2123. PubMed ID: 35105287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]